Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
427 participants
OBSERVATIONAL
2000-07-31
2004-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
NCT06833138
Biomarkers Predicting Atrial High Rate Episodes in Cardiac Implantable Electronic Device Recipients
NCT05475860
Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study)
NCT03303872
Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome.
NCT02034526
Excessive Supraventricular Activity and Atrial Fibrillation
NCT04593498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
pacemaker patients with previously diagnosed AT.
No interventions assigned to this group
2
pacemaker patients without previously diagnosed AT.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No previous history of pacemaker implantation
* Patients 50 years of age or older
Exclusion Criteria
* Patients with medical conditions that would limit study participation
* Patients inaccessible for follow-up at the study center
* Patients incapable of providing Informed Consent
* Patients with NYHA classification of IV
* Patients with a history of neurocardiogenic syncope, long QT syndrome, or Hypertrophic Obstructive Cardiomyopathy (HOCM)
* Patients taking Sotalol or Amiodorone
* Patients with a history of a prior ICD or pacemaker implantation.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
CRDM Clincial Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M. V. Orlov, MD
Role: PRINCIPAL_INVESTIGATOR
Tufts University School of Medicine
J.K. Ghali, MD
Role: PRINCIPAL_INVESTIGATOR
Louisiana State University Health Sciences Center in New Orleans
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hot Springs, Arkansas, United States
Little Rock, Arkansas, United States
Fresno, California, United States
Glendale, California, United States
San Diego, California, United States
Daytona Beach, Florida, United States
Orlando, Florida, United States
Hammond, Indiana, United States
Hobart, Indiana, United States
Munster, Indiana, United States
Louisville, Kentucky, United States
Marrero, Louisiana, United States
Shreveport, Louisiana, United States
Salisbury, Maryland, United States
West Roxbury, Massachusetts, United States
Saint Cloud, Minnesota, United States
Livingston, New Jersey, United States
Patterson, New Jersey, United States
Flushing, New York, United States
Rochester, New York, United States
Syracuse, New York, United States
The Bronx, New York, United States
Charlotte, North Carolina, United States
Gastonia, North Carolina, United States
Greenville, North Carolina, United States
Willimington, North Carolina, United States
Oklahoma City, Oklahoma, United States
Bethlehem, Pennsylvania, United States
Mechanicsburg, Pennsylvania, United States
Scranton, Pennsylvania, United States
Wynnewood, Pennsylvania, United States
Providence, Rhode Island, United States
Chattanooga, Tennessee, United States
Dallas, Texas, United States
Falls Church, Virginia, United States
Richmond, Virginia, United States
Milwaukee, Wisconsin, United States
Ashford, , Australia
Ballarat, , Australia
Bedford Park, , Australia
Lille, , France
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ghali JK, Orlov MV, Araghi-Niknam M, Sherfesee L, Hettrick DA. The influence of symptoms and device detected atrial tachyarrhythmias on medical management: insights from A-HIRATE. Pacing Clin Electrophysiol. 2007 Jul;30(7):850-7. doi: 10.1111/j.1540-8159.2007.00772.x.
Orlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA; Atrial High Rate Trial Investigators. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol. 2007 Mar;30(3):404-11. doi: 10.1111/j.1540-8159.2007.00682.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.